News

A potential COVID-19 vaccine from drug manufacturers Pfizer and BioNTech needs to be distributed in extreme cold, causing an uptick in sales of dry ice and medical-grade freezers. This is why Pfizer's potential COVID-19 vaccine is boosting dry ice sales currently.

The Massachusetts-based biotechnology company Moderna announced Monday that its potential COVID-19 vaccine has proven 94.5 percent effective during a trial, making it the second possible coronavirus vaccine to have a high success rate. How does it compare to Pfizer's vaccine?

If you're struggling to stay vigilant and aware of what's happening with the COVID-19 pandemic, you're not alone: COVID fatigue is a real thing, and it's dangerous.

We've all heard how eating right and exercising is good for your heart, but if you struggle with those healthy habits from day to day, just hit the hay.

As of today, the world's largest online retailer, Amazon, has announced its entry into the $300 billion pharmacy market with the launch of Amazon Pharmacy. Here's what you need to know.

The grim COVID-19 infection count just keeps on soaring. Why is the virus roaring back with a vengeance, or did it ever actually go away?

Moderna — the Cambridge, Massachusetts-based biotechnology company — has just shot to stardom with the news that early data shows that its new coronavirus vaccine shows a remarkable 94.5 percent rate of efficacy. This is all in spite of the fact that Moderna has yet to produce an FDA-approved drug.

For so many of us, a COVID-19 vaccine holds the hope of returning to a semblance of normal life. So, news from drug-maker Moderna is being cheered from coast to coast as they announced their vaccine has shown to be 94.5 percent effective in early testing.

Genetics and gender may determine both your risk of contracting COVID-19 and how sick you'll become, according to two new studies researching genes and the body's immune system.

Like one of as many as 11 percent of American women between the ages of 15 and 44, Roberts was diagnosed with endometriosis in her late 20s, a condition that went unrecognized during her adolescence despite reporting symptoms to her doctor.

As the biotech world moves closer to getting a COVID-19 vaccine approved, details about the specifics of such treatment are coming into focus. One question is — how much the vaccine is going to cost? And do Americans need to budget for it, or will health insurance cover it?

With news of pharmaceutical giant Pfizer and German biotech company BioNTech announcing positive early results from their COVID-19 vaccine trial, many ears pricked up upon hearing the name of the familiar drug maker behind brands such as Advil, Robitussin, Zoloft, and Viagra.

Pzifer, in collaboration with German biotechnology company BioNTech, has released new information about the development of its coronavirus vaccine. While these results are promising, more work needs to be done. If things are good to go, though, when could it be available?

For months, the world has been eagerly awaiting news of advancements in the development of a vaccine for COVID-19. One vaccine trial has finally announced some promising results. What has to happen before this COVID-19 vaccine is approved?

The death of beloved Jeopardy! host Alex Trebek on Sunday spotlights the aggressiveness of pancreatic cancer, a disease with a poor survival rate — about 10 percent over five years.

Al Roker, the Today weatherman and co-host, has revealed a recent cancer diagnosis. The popular TV personality shared that he will undergo surgery next week. This will not be his first surgery, however — he's been in and out of operating room doors more than a few times over the course of his life.

Social distancing and other safeguards to curtail the spread of the coronavirus could have the bonus benefit of clamping down on the spread of the flu, health experts say.

Like millions of other Americans, you likely woke up over these last few mornings feeling a certain level of stress as you checked for election results. While you wait, it's important to tame your stress and channel that energy into something more productive than doomscrolling.

Do you feel stressed, tired, and overwhelmed when you think about the election? Do you feel the anxious urge to constantly check your news feed? You're not alone. Election-related angst is so prevalent that experts have given it a name: election stress disorder.

Early on in the pandemic, doctors noticed a symptom among patients with coronavirus: a loss of taste. Until now, they've been unsure why the virus causes this, but new research indicates that cells in the mouth are a key player in both the loss of taste and the growth and spread of the illness.

If scientists are successful, the phrase, 'There's an app for that!' soon could apply to being able to detect the coronavirus, even in people who show no symptoms.

A new study of grocery workers in Boston, Massachusetts, suggests that grocery store employees are at greater risk of contracting COVID-19. Also, since a majority of those in the study showed no symptoms, these workers could be a significant transmission source of the coronavirus, researchers said.

Experts are suggesting we reconsider our notion of the 'lonely gamer,' and instead recognize that there is social value to video games — especially in the face of a pandemic, where social distancing is making it difficult for teens to hang out in the usual ways.

More women ages 30 and older are experiencing pregnancy-related heart attacks, especially during the postpartum period, according to new research published in the Journal of the American Heart Association.

'Well, someone woke up on the wrong side of the bed this morning!' We've all heard this before, or remarked it to a grumpy, cereal-bowl-slamming roommate, partner, or other cohabitant. As it turns out, there is an actual link between a sour disposition and lack of sleep.

Two studies released this month show that men worldwide are less likely to perceive COVID-19 as a serious health problem and to follow preventative behaviors — something that puts their lives more in jeopardy.

If you were ahead of the curve on what The New York Times called the Peloton panic-buying trend, or if you bought one secondhand, it's time to take a good look at your clip-in pedals — they may be subject to a recall.